RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19733917http://www.w3.org/2000/01/rdf-schema#comment"Epitope reactivity of multiple sclerosis (MS) plasma antibodies against the Epstein-Barr virus protein EBNA-1 and its association with HLA DRB1*1501 status was investigated in a case-referent study. Based on EBNA-1 fragment reactivity and the effect of peptide blocking, four 29-36 amino acid long EBNA-1 fragments were selected for detailed studies. MS cases had increased antibody reactivity against several EBNA-1 domains, of which antibodies against EBNA-1 (amino acid 385-420) in HLA DRB1*1501 positive individuals were associated with a 24-fold risk increase for MS. The data need confirmation in a larger sample but suggest a role for this epitope in the autoimmune pathogenesis of MS."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.org/dc/terms/identifier"doi:10.1016/j.jneuroim.2009.08.004"xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/author"Sundstrom P."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/author"Lundgren E."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/author"Nystrom M."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/author"Ruuth K."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/name"J Neuroimmunol"xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/pages"102-107"xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/title"Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis."xsd:string
http://purl.uniprot.org/citations/19733917http://purl.uniprot.org/core/volume"215"xsd:string
http://purl.uniprot.org/citations/19733917http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19733917
http://purl.uniprot.org/citations/19733917http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19733917
http://purl.uniprot.org/uniprot/#_A0A0A7C3H3-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0A7C3I1-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0A7C3I5-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0A0WDZ3-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0E3DD60-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0E3DD66-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A141AZI1-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A141AZI3-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A141AZI4-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0A0WAE5-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917
http://purl.uniprot.org/uniprot/#_A0A0A0WB88-mappedCitation-19733917http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19733917